VR Logo

HOOKIPA Pharma Inc. (HOOK) download report


Healthcare | Biotechnology & Pharma Research

HOOKIPA Pharma Inc. (HOOK) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform.

IPO Date: 18-Apr-2019

CEO & Director: Mr. Joern Aldag

CFO & Director: Dr. Reinhard Kandera Ph.D.

Listing: NASDAQ: HOOK

Country: United States

Headquarters: New York, NY

Website: https://www.hookipapharma.com

Key Facts

Market cap: $94.62 Mln

Revenue (TTM): $5.34 Mln

Earnings (TTM): $-76.40 Mln

Cash: $140.83 Mln

Total Debt: $10.47 Mln

Insider's Holding: 8.39%

Liquidity: Low

52 Week range: $1.25 - 9.45

Shares outstanding: 50,872,700

5 Years Aggregate:

  • CFO: $-174.00 Mln
  • EBITDA: $-182.94 Mln
  • Net Profit: $-191.74 Mln

Stock Performance

Time Period HOOKIPA Pharma (HOOK) S&P BSE Sensex S&P Small-Cap 600
YTD-27.68-8.74-16.95
1 month3.37-2.01-4.64
3 months-10.85-7.32-12.54
1 Year-81.900.45-16.18
3 Years-35.0910.328.06
5 Years--11.296.38
10 Years--12.1410.57
As on 27-Jun-2022
Year HOOKIPA Pharma (HOOK) S&P Small-Cap 600 S&P BSE Sensex
2021-78.9925.2721.99
2020-9.329.5715.75